Oasmia

Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

Read more

Press releases

August 23, 2019 Regulatory press release
Oasmia ADSs delisted from NASDAQ in the US
August 20, 2019 Regulatory press release
Nomination committee in Oasmia for the 2019 AGM
August 15, 2019 Regulatory press release
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calender

All press releases

Financial reports

Calendar

September 5, 2019 Annual Report 2018 / 2019
September 6, 2019 Interim Report May – July 2019
September 26, 2019 Annual General Meeting

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK